Sepsis is a complex condition in which a systematic inflammatory response is activated by infection, setting off a cascade of events that can culminate in multiple organ failure and death. New therapeutic strategies are urgently needed, with a key goal being the development of drugs that can be administered when sepsis is already underway. Inhibition of the transcription factor NF-κB has been shown to have a protective role in sepsis. Here, Christoph Thiemermann and colleagues tested the effect of inhibiting the IKK complex, which is involved in the early stages of NF-κB activation, on organ dysfunction and injury in mouse models of sepsis. They report that sepsis-induced organ injury is attenuated upon delayed administration of an IKK inhibitor, suggesting that this inhibitor could be given to sepsis patients during the devastating late stages in disease progression. Page 1031
- Written by editorial staff. © 2013. Published by The Company of Biologists Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Article navigation
Related articles
Cited by...
More in this TOC section
Similar articles
Other journals from The Company of Biologists
DMM and COVID-19
We are aware that the COVID-19 pandemic is having an unprecedented impact on researchers worldwide. The Editors of all The Company of Biologists’ journals have been considering ways in which we can alleviate concerns that members of our community may have around publishing activities during this time. Read about the actions we are taking at this time.
Please don’t hesitate to contact the Editorial Office if you have any questions or concerns.
Supporting communities at The Company of Biologists
Throughout all fields of biology there are vibrant, active and engaged communities. We’re proud to host, alongside our journals, three dedicated community sites to extend our support to biologists everywhere. Find out more about the Node, preLights and FocalPlane.
Editor’s Choice - Biomimetic device and foreign body reaction cooperate for efficient tumour cell capture in murine advanced ovarian cancer
Miguel Abal and colleagues implanted a biomimetic device to recapitulate the peritoneal metastatic niche and to efficiently capture disseminating ovarian cancer cells in vivo.
Interviews – Alec, Sara, Dimitrije, Amélie and Malabika
DMM first authors Alec Nickolls, Sara Ibrahim, Dimitrije Stanković, Amélie Bacle and Malabika Chakrabarti all share the stories behind their latest research.
Understanding the impact of fibroblast heterogeneity on skin fibrosis
In their new Review, Michael Longaker and colleagues discuss the complex aspects of fibroblast heterogeneity and the different roles of fibroblast subpopulations to help overcome skin scarring and fibrosis.